Philips Intera MR Subject Of Warning Letter For Unapproved Perfusion Claim
This article was originally published in The Gray Sheet
Executive Summary
FDA's recent warning letter to Philips Medical regarding promotion of magnetic resonance (MR) scanners for cardiac perfusion studies is symptomatic of the industry's struggle to find a regulatory pathway to approval for the indication
You may also be interested in...
Philips Medical Systems Incurs Second Warning Letter Since August
Corrective actions related to a warning letter Philips Medical Systems received Oct. 16 will be addressed during a meeting between the company and FDA the week of Nov. 3
Philips Medical Systems Incurs Second Warning Letter Since August
Corrective actions related to a warning letter Philips Medical Systems received Oct. 16 will be addressed during a meeting between the company and FDA the week of Nov. 3
CDRH Review Of Expanded Imaging Agent Indications Urged By NEMA
CDRH should serve as the lead reviewer for premarket applications of already-approved contrast agents indicated for use with diagnostic imaging devices, according to Philips Medical Systems VP-Quality & Regulatory Affairs Terry Sweeney